FIT Biotech

Our vision

Our mission is to be a globally recognized DNA-vaccine and gene therapy company, through our own research.

Read more

  • Our success

    We measure our success in the value of human life

FIT Biotech aims to make a difference.

R&D Publications

Press release July 27th, 2015

Press release July 27th, 2015

FIT Biotech appoints Dr. Milla Koistinaho as Chief Operating Officer

Read press release here

Lehdistötiedote 27.7.2015

Lehdistötiedote 27.7.2015

FIT Biotech nimittää dosentti Koistinahon varatoimitusjohtajaksi

Lue lehdistötiedote tästä

Company release July 16th, 2015

Company release July 16th, 2015

The Board of Directors of FIT Biotech Decides on Conversion of Shares

Read company release here

Yhtiötiedote 16.7.2015

Yhtiötiedote 16.7.2015

FIT Biotechin hallitus on päättänyt osakemuunnoista

Lue yhtiötiedote tästä

Press release July 6th, 2015

Press release July 6th, 2015

FIT Biotech in Consortium Selected For Final Negotiations with EC

Read press release here

RESEARCH & DEVELOPMENT

FIT Biotech’s most important R&D activity since the start of its operations has been the development of an HIV vaccine.

R&D Publications